CD07 Investigational Site — Chicago, Illinois

CD07 Investigational Site is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

CD07 Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Triple Negative Breast Neoplasms.

Sponsors: CytoDyn, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CD07 Investigational Site?

CD07 Investigational Site has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CD07 Investigational Site conducted?

CD07 Investigational Site has 1 clinical trials on record. Their work covers Triple Negative Breast Neoplasms.

Is CD07 Investigational Site accredited by Crixeo Health?

CD07 Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CD07 Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.